Updated Jul 16, 2026 · Last SEC filing 2026-06-29
CVS HEALTH Corp (CVS) has filed 18 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-29. 2 Form 8-K material event filings were reported by CVS in the last 90 days. 3 Form 144 notices of proposed sale were filed for CVS stock. InsiderAlpha tracks every CVS SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Retail-Drug Stores and Proprietary Stores (SIC 5912) |
|---|---|
| SEC CIK | 0000064803 |
| Form 4 filings (90d) | 18 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 3 |
| Latest Form 4 filing | 2026-06-29 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Clark James David | SVP, Cont & Chief Acct Officer | F — Tax withholding / forfeiture | 454 | $90.98 | $41K | SEC | |
| Newman Brian | EVP, Chief Financial Officer | F — Tax withholding / forfeiture | 2.5K | $90.98 | $225K | SEC | |
| Compton-Phillips Amy | EVP, Chief Medical Officer | F — Tax withholding / forfeiture | 7.6K | $90.98 | $693K | SEC | |
| ROBBINS LARRY | Insider | S — Open-market sale | 370.5K | $93.45 | $34.62M | SEC | |
| AGUIRRE FERNANDO | Director | D — Derivative transaction | 1.6K | $93.50 | $146K | SEC | |
| ROBBINS LARRY | Insider | S — Open-market sale | 800 | $96.28 | $77K | SEC | |
| ROBBINS LARRY | Insider | S — Open-market sale | 66.9K | $95.67 | $6.40M | SEC | |
| ROBBINS LARRY | Insider | S — Open-market sale | 152.7K | $94.81 | $14.48M | SEC | |
| AGUIRRE FERNANDO | Director | D — Derivative transaction | 30.4K | $93.78 | $2.85M | SEC | |
| ROBBINS LARRY | Insider | S — Open-market sale | 797.6K | $93.48 | $74.56M | SEC | |
| ROBBINS LARRY | Insider | S — Open-market sale | 1.98M | $94.45 | $187.33M | SEC | |
| ROBBINS LARRY | Insider | S — Open-market sale | 151 | $95.18 | $14K | SEC | |
| KIRBY J SCOTT | Director | A — Grant or award | 1.4K | $97.15 | $141K | SEC | |
| Norwalk Leslie V | Director | A — Grant or award | 1.4K | $97.15 | $141K | SEC | |
| SANSONE GUY P | Director | A — Grant or award | 1.4K | $97.15 | $141K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for CVS HEALTH Corp (CVS). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| ROBBINS LARRY | 9 | $352.93M |
| AGUIRRE FERNANDO | 3 | $3.15M |
| Newman Brian | 1 | $225K |
| Finucane Anne A. | 1 | $150K |
| KIRBY J SCOTT | 1 | $141K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CVS insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live CVS dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.